NCT02680678

Brief Summary

Prevention of postspinal hypotension after spinal anesthesia for caesarian section by use of preoperative or intraoperative volume replacement. The comparison of crystalloid and colloid infusions and their timing via perfusion index and plethysmographic variability index.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2014

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

February 9, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 11, 2016

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

January 22, 2020

Status Verified

January 1, 2020

Enrollment Period

2.3 years

First QC Date

February 9, 2016

Last Update Submit

January 17, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of participants in each group who develop hypotension, and correlation between hypotension and Perfusion Index (PI) and Plethysmographic Variability Index (PVI) scores

    Hypotension is going tobe measured in mmHG in 5 minute intervals and PI and PVI measurements are also recorded at the same time intervals. A decrease in blood presssure exceeding % 20 of the preoperative basal blood pressure measurement will be recorded as hypotension. The number of patients who develop hypotension will be recorded. Statistic difference will be avaluated between groups. Hypotensive episodes are going to be comparised with the PI and PVI measurements at the same time period and evaluation for correlation will be performed.

    Measurements will be performed at 5 minute intervals beginning 15 minutes prior to the operation, throughout the whole operation untill the end.

Study Arms (4)

Colloid preload

ACTIVE COMPARATOR

20 patients each patient receives 7 ml/kg of gelatin solution (gelofusin) 15 minutes before spinal anesthesia.

Other: Colloid Preload

Colloid Co-load

ACTIVE COMPARATOR

20 patients each patient receives 7 ml/kg of gelatin solution (gelofusin) beginning with spinal anesthesia.

Other: colloid co-load

Crystalloid Preload

ACTIVE COMPARATOR

20 patients each patient receives 20 ml/kg of Ringer's lactate solution 15 minutes before spinal anesthesia.

Other: Crystalloid preload

Crystalloid Co-load

ACTIVE COMPARATOR

20 patients each patient receives 20 ml/kg of Ringer's lactate solution beginning with spinal anesthesia.

Other: Crystalloid Co-load

Interventions

preload infusion

Also known as: Gelofusin
Colloid preload

co-load infusion

Also known as: gelofusin
Colloid Co-load

preload infusion

Also known as: Ringers lactate solution
Crystalloid Preload

co-load infusion

Also known as: Ringers lactate solution
Crystalloid Co-load

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • pregnant 37-41 weeks
  • one fetus
  • scheduled for C/S under spinal anesthesia
  • accepting to participate

You may not qualify if:

  • Emergency surgery
  • placenta previa
  • preeclampsia
  • cardiovascular and cerebrovascular comorbidities
  • morbid obesity (BMI\>40)
  • pregnancy weeks \<36 and \> 41
  • The use of vasoconstrictors
  • Severe Anemia ( Hb \<9 g/dl)
  • Refusal or known contraindication for spinal anesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Balikesir University Faculty of Medicine

Balıkesir, 10145, Turkey (Türkiye)

Location

MeSH Terms

Interventions

succinylated gelatinRinger's Lactate

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Hafize Fisun Demir

    Balikesir University School of Medicine Department of Anesthesia and Reanimation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
the outcome accessor and care provider will be aware in which gropu the patient was
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: 4 group of patients were sheduled to receive either kristalloid or kolloid two gropus before and two groups during anesthesia induction
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 9, 2016

First Posted

February 11, 2016

Study Start

April 1, 2014

Primary Completion

August 1, 2016

Study Completion

December 1, 2016

Last Updated

January 22, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations